| Where now for post-normal science?: a critical review of its development, definitions, and uses J Turnpenny, M Jones, I Lorenzoni Science, Technology, & Human Values 36 (3), 287-306, 2011 | 187 | 2011 |
| Noisy and definitely not normal: responding to wicked issues in the environment, energy and health J Turnpenny, I Lorenzoni, M Jones Environmental Science & Policy 12 (3), 347-358, 2009 | 174 | 2009 |
| Climate change, human genetics, and post-normality in the UK I Lorenzoni, M Jones, JR Turnpenny Futures 39 (1), 65-82, 2007 | 120 | 2007 |
| Locating scientific citizenship: The institutional contexts and cultures of public engagement K Bickerstaff, I Lorenzoni, M Jones, N Pidgeon Science, Technology, & Human Values 35 (4), 474-500, 2010 | 119 | 2010 |
| Biobanks and bioethics: the politics of legitimation B Salter, M Jones Journal of European Public Policy 12 (4), 710-732, 2005 | 111 | 2005 |
| The governance of human genetics: policy discourse and constructions of public trust M Jones, B Salter New Genetics and Society 22 (1), 21-41, 2003 | 85 | 2003 |
| Human genetic technologies, European governance and the politics of bioethics B Salter, M Jones Nature Reviews Genetics 3 (10), 808-814, 2002 | 62 | 2002 |
| Regulating human genetics: the changing politics of biotechnology governance in the European Union B Salter, M Jones Health, Risk & Society 4 (3), 325-340, 2002 | 58 | 2002 |
| Standardization and omics science: technical and social dimensions are inseparable and demand symmetrical study C Holmes, F McDonald, M Jones, V Ozdemir, JE Graham OMICS: A Journal of Integrative Biology 14 (3), 327-332, 2010 | 40 | 2010 |
| Institutional policy learning and public consultation: the Canadian xenotransplantation experience M Jones, E Einsiedel Social science & medicine 73 (5), 655-662, 2011 | 37 | 2011 |
| Mapping actors involved in climate change policy networks in the UK J Turnpenny, A Haxeltine, I Lorenzoni, T O’Riordan, M Jones Norwich: Tyndall Centre for Climate Change, Working Paper 66, 2005 | 29 | 2005 |
| Cultures, contexts and commitments in the governance of controversial technologies: US, UK and Canadian publics and xenotransplantation policy development EF Einsiedel, M Jones, M Brierley Science and public policy 38 (8), 619-628, 2011 | 28 | 2011 |
| Change in the policy community of human genetics: a pragmatic approach to open governance B Salter, M Jones Policy & Politics 34 (2), 347-366, 2006 | 22 | 2006 |
| Exploring the post-genomic world: Differing explanatory and manipulatory functions of post-genomic sciences C Holmes, SM Carlson, F McDonald, M Jones, J Graham New Genetics and Society 35 (1), 49-68, 2016 | 18 | 2016 |
| Proceeding carefully: Assisted human reproduction policy in Canada M Jones, B Salter Public Understanding of Science 19 (4), 420-434, 2010 | 14 | 2010 |
| Separated at birth? Consensus and contention in the UK agriculture and human biotechnology commissions M Jones, J Walls, T Horlick-Jones Science and Public Policy 33 (10), 729-744, 2006 | 14 | 2006 |
| Policy legitimation, expert advice, and objectivity:‘opening’the UK governance framework for human genetics M Jones Social Epistemology 18 (2-3), 247-270, 2004 | 11 | 2004 |
| Rendre évident: une approche symétrique de la réglementation des produits thérapeutiques J Graham, M Jones Sociologie et sociétés 42 (2), 153-180, 2010 | 10 | 2010 |
| Multiple institutional rationalities in the regulation of health technologies: An ethnographic examination M Jones, JE Graham Science and Public Policy 36 (6), 445-455, 2009 | 10 | 2009 |
| Interventions to reach underscreened populations: a narrative review for planning cancer screening initiatives M Jones, B Ross, A Cloth, L Heller International Journal of Public Health 60, 437-447, 2015 | 9 | 2015 |
Christina HolmesSt Francis Xavier UniversityBestätigte E-Mail-Adresse bei stfx.ca
